Abuelgasim, K. A., Shammari, R. A., Alshieban, S., Alahmari, B., Alzahrani, M., Alhejazi, A., . . . Damlaj, M. (2021). Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience. Leuk Res Rep.
Citação norma ChicagoAbuelgasim, Khadega A., Raed Al Shammari, Saeed Alshieban, Bader Alahmari, Mohsen Alzahrani, Ayman Alhejazi, Ahmed Alaskar, and Moussab Damlaj. "Impact of Cluster of Differentiation 20 Expression and Rituximab Therapy in Classical Hodgkin Lymphoma: Real World Experience." Leuk Res Rep 2021.
Citação norma MLAAbuelgasim, Khadega A., et al. "Impact of Cluster of Differentiation 20 Expression and Rituximab Therapy in Classical Hodgkin Lymphoma: Real World Experience." Leuk Res Rep 2021.